Group velocity, phase velocity, and dispersion in human calcaneus in vivo.
Commercial bone sonometers measure broadband ultrasonic attenuation and/or speed of sound (SOS) in order to assess bone status. Phase velocity, which is usually measured in frequency domain, is a fundamental material property of bone that is related to SOS, which is usually measured in time domain. Four previous in vitro studies indicate that phase velocity in human cancellous bone decreases with frequency (i.e., negative dispersion). In order to investigate frequency-dependent phase velocity in vivo, through-transmission measurements were performed in 73 women using a GE Lunar Achilles Insight commercial bone sonometer. Average phase velocity at 500 kHz was 1489 +/- 55 m/s (mean +/- standard deviation). Average dispersion rate was -59 +/- 52 m/sMHz. Group velocity was usually lower than phase velocity, as is expected for negatively dispersive media. Using a stratified model to represent cancellous bone, the reductions in phase velocity and dispersion rate in vivo as opposed to in vitro can be explained by (1) the presence of marrow instead of water as a fluid filler, and (2) the decreased porosity of bones of living (compared with deceased) subjects.
Wear
Keith A
KA
U.S. Food and Drug Administration, Center for Devices and Radiological Health, Rockville, Maryland 20852, USA. kaw@cdrh.fda.gov
D015519:Bone Density / Q000502:physiology*; D002111:Calcaneus / Q000000981:diagnostic imaging*; D003720:Densitometry / Q000295:instrumentation*; D006801:Humans; D008954:Models, Biological; D014463:Ultrasonography